Role of oxidative stress as physiopathologic factor in the preterm infant;Il ruolo dello stress ossidativo come fattore fisiopatologico nel nato pretermine

Minerva Pediatrica

Volumn 56, Issue 4, 2004, Pages 381-394

  Dani, C ^a,b   Cecchi, A ^b   Bertini, G ^a  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Infant, premature; Oxidative stress; Reactive oxygen species

Indexed keywords

ANTIOXIDANT; BILIRUBIN; CATALASE; CYTOKINE; GLUTATHIONE PEROXIDASE; HEME OXYGENASE 1; HYDROGEN PEROXIDE; INTERLEUKIN 10; INTERLEUKIN 1BETA; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR ALPHA;

BRAIN HEMORRHAGE; BRAIN HYPOXIA; BRAIN INJURY; BRAIN ISCHEMIA; HUMAN; HYPERBILIRUBINEMIA; INFANT; LUNG DYSPLASIA; NECROTIZING ENTEROCOLITIS; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PREMATURITY; RETROLENTAL FIBROPLASIA; REVIEW;

BRONCHOPULMONARY DYSPLASIA; ENTEROCOLITIS, NECROTIZING; HUMANS; HYPOXIA-ISCHEMIA, BRAIN; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; JAUNDICE, NEONATAL; OXIDATIVE STRESS; RETINOPATHY OF PREMATURITY;

EID: 7644234028     PISSN: 00264946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (90)

1. Buhimschi IA, Buhimschi CS, Pupkin M, Weiner CP. Beneficial impact of term labor: nonenzymatic antioxidant reserve in the human fetus. Am J Obstet Gynecol 2003;189:181-8.
2. Halliwell B, Gutteridge JM. Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol 1990;186:1-85.
3. Kelly FJ. Free radicals disorders of preterm infants. Br Med Bull 1993;49:668-78.
4. Hardy P, Peri KG, Lahaie I, Varma DR, Chemtob S. Increased nitric oxide synthase and action preclude choroidal vasoconstriction to hyperoxia in newborn pig. Circ Res 1996;79:504-11.
5. Chemtob S, Abran D, Hardy P. Peroxide-cyclooxygenase interactions in postasphyxial changes in retinal and choroidal hemodinamics. J Appl Physiol 1995;78: 2039-46.
6. Abran D, Varma DR, Chemtob S. Increased thromboxane mediated contractions of retinal vessels of newborn pig to peroxides. Am J Physiol 1995;268:H628-32.
7. James L, Greenough A, Naik S. The effect of blood transfusion on oxygenation in premature ventilated neonates. Eur J Pediatr 1997;156:139-41.
8. Cooke RWI, Clark D, Nickel-Dwyer M, Weindling AM. The apparent role of blood transfusion in the development of retinopathy of prematurity. Eur J Pediatr 1993;152;833-6.
9. Dani C, Martelli E, Bertini G, Pezzati M, Filippi L, Rossetti M et al. Bilirubin plasma level and oxidative stress in preterm infants. Arch Dis Child Fetal Neonatal Ed 2003;88:F119-23.
10. Lackman GM, Schnieder C, Bohner J. Gestational age-dependent reference values for iron and selected proteins of iron metabolism in serum premature human neonatess. Biol Neonate 1998;74:208-13.
11. Siimes MA, Addiego JE, Dallman PR. Ferritn in serum, diagnosis of iron deficiency and overload in infants and children. Blood 1974;43:581-90.
12. Gutteridge JMC. Fate of oxygen free radicals an extracellular fluid. Biochem Soc Trans 1982;10:72-3.
13. ed ed. Philadelphia, PA: Lippincott; 1999.p.509-32.
14. Ware J, Taeusch HW, Soll RF, McCormick MC. Health and developmental outcomes of a surfactant controlled trial: follow-up at 2 years. Pediatrics 1990;85:1103-7. Erratum in. Pediatrics 1991;87:412.
15. Ware J, Taeusch HW, Soll RF, McCormick MC. Health and developmental outcomes of a surfactant controlled trial: follow-up at 2 years. Pediatrics 1990;85:1103-7. Erratum in. Pediatrics 1991;87:412.
16. Pierce MR, Bancalari E. The role of inflammation in the pathogenesis of bronchopulmonary dysplasia. Pediatr Pulmonol 1995;19:371-6.
17. Saugstad OD. Bronchopumonary dysplasia-oxidative stress and antioxidants. Semin Neonatol 2003;8:39-49.
18. Groneck P, Speer CP. Inflammatory mediators and bronchopulmonary dysplasia. Arch Dis Child Fetal Neonatal Ed 1995;73:F1-3.
19. Speer CP, Groneck P. Oxygen radicals, cytokines, adhesion molecules and lung injury in neonates. Semin Neonatol 1998;3:219-28.
20. Davis JM, Rosenfeld WN, Sanders RJ, Gonenne A. Prophylactic effects of recombinant human superoxide dismutase in neonatal lung injury. J Appl Physiol 1993;74:2234-41.
21. Davis JM, Rosenfeld WN, Richter SE, Parad R, Gewolb IH, Spitezer AR et al. Safety and pharmacokinetic of multiple doses of recombinant human CuZn superoxide dismutase administrated intratracheally to premature neonates with respiratory distress syndrome. Pediatrics 1997;100:24-30.
22. Ilizarov a, Koo HC, Bapat R, Li Y, Pollack S, Davis JM. Overespression of manganese superoxide dismutase protects lung epithelial cells against oxidant injury. Am J Respir Cell Mol Biol 2001;24:436-41.
23. Davis JM. Role of oxidant injury in the pathogenesis of neonatal lung disease. Acta Paediatr Suppl 2002;437: 23-5.
24. Robbins CG, Horowitz S, Merrit TA, Kheiter A, Tierney J, Narula P et al. Recombinant human superoxide dismutase reduces lung injury caused by inhaled nitric oxide and hyperoxia. Am J Physiol 1997;272:L903-7.
25. Rosenfeld WN, Davis JM, Parton L, Richter SE, Price A, Plaster E et al. Safety and pharmacokinetics of recombinant human superoxide dismutase administrated antratracheally to premature neonates with respiratory distress syndrome. Pediatrics 1996;97:811-7.
26. Davis JM, Paracl RB, Michele T, Allred E, Price A, Rosenfeld W. Pulmonary outcome at 1 year corrected age in premature infants treated at birth with recombinant human CuZn superoxide dismutase. Pediatrics 2003:111:469-76.
27. Ahola T, Lapatto R, Raivio KL, Selander B, Stigson L, Jonsson B et al. N-acetylcysteine does not prevent bronchopulmonary dysplasia in immature infants; a randomized controlled trial. J Pediatr 2003;143:713-9.
28. Smith CV, Hansen TN, Martin NE, McMicken HW, Elliot SJ. Oxidant stress responses in premature infants during exposure to hyperoxia. Pediatr Res 1993;34:360-5.
29. Jain A, Metha T, Auld PA, Rodrigues J, Ward RF, Schwartz MK et al. Glutathione metabolism in newborns: evidence for glutathione deficiency in plasma, bronchoalveolar lavage fluid, and lymphocytes in prematures. Pediatr Pulmonol 1995;20:160-6.
30. Holm BA, Notter RH, Siegle J, Matalon S. Pulmonary physiological and surfactant changes during injury and recovery from hyperoxia. J Appl Physiol 1985;59:1402-9.
31. Cooke RWJ, Drury JA, Yoxall CW, James C. Blood transfusion and chronic lung disease in preterm infants. Euv J Fed 1997;156:47-50.
32. Silvers KM, Gibson AT, Russell JM, Powers HJ. Antioxidant activity, packed cell transfusions, and outcome in premature infants. Arch Dis Child Fetal Neonatal Ed 1998;78:F214-9.
33. Moison RM, Palinckx JJ, Roest M, Houdkamf E, Berger HM. Induction of lipid peroxidation of pulmonary surfactant by plasma of preterm babies. Lancet 1993,341: 79-82.
34. Dorrepaal CA, Berger HM, Benders MJ, Van Zoeren-Grobben D, Van de Bor M. Nonprotein-bound iron in postasphyxial reperfusion injury in the newborn. Pediatrics 1996;98:883-9.
35. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxil radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990;87:1620-4.
36. Potte CF, Kuo Nt, Farver CF, McMahon JT, Chang CH, Agani FH et al. Effects of hyperoxia on nitric oxide synthase expression, nitric oxide activity, and lung injury in rat pups. Pediatr Res 1999;45:8-13.
37. Hallman M, Waffarn F, Bry K, Turbow R, Kleinman MT, Montz WJ et al. Surfactant dysfuction after inhalation of nitric oxide. J Appl Physiol 1996;80:2026-34.
38. Haddad IY, Ischiropoulos H, Holm BA, Beckman JS, Baker JR, Matalon S. Mechanism of peroxynitrite-induced injury to lung surfactants. Am J Physiol 1993;265: L555-64.
39. Lipkin PH, Davidson D, Spivak L, Straube R, Rhines J, Chang TC et al. Neurodevelopmental and medical outcomes of persistent pulmonary hypertension in term newborns treated with nitric oxide. J Pediatr 2002;140: 306-10.
40. SiesJo BK, Siesjo P. Mechanism of secondary brain injury. Eur J Anaesthesiol 1996;13:247-68.
41. Buonocore G, Perrone S, Bracci R. Free radicals and brain damage. Biol Neonate 2001;79:180-6.
42. Ivacko JA, Sun, RS, Silverstein FS. Hypoxic-ischemic brain injury induces an acute microglial reaction in perinatal rats. Pediatr Res 1995;39:39-47.
43. Mishra OP, Delivoria-Papadopoulos M. Cellular mechanism of hypoxic injury in the developing brain. Brain Res Bull 1998;48:233-8.
44. Kowaltowski AJ, Vercesi AE. Mithocondrial damage induced by conditions of oxidative stress. Free Rad Biol Med 1999;26:463-71.
45. Volpe JJ. Neurology of the newborn. 4th ed. Philadelphia: WB Saunders; 2001.
46. Back SA, Can X, Li Y, Rosenberg PR, Volpe JJ. Maturation dependent vulnerability of oligodendrocytes to oxidative stress induced death caused by glutathione depletion. J Neurosci 1998;18:6241-53.
47. Back SA, Luo NL, Borestein NS, Levine JM, Volpe JJ, Kinney HC. Late oligodendrocyte progenitors coincide with the development window of vulnerability for human perinatal white matter injury. J Neurosci 2001;21: 1302-12.
48. Brand A, Gil S, Seger R, Yavin E. Lipid constituents in oligodendroglial cells alter susceptibility to H2O2-induced apoptotic cell death via ERK activation. J Neurochem 2001;76:910-8.
49. Houdou S, Kuruta H, Hasegawa M, Konomi H, Takashima S, Suzuki Y et al. Developmental immunohistochemistry of catalase in the human brain. Brain Res 1991;556:267-70.
50. Chan OH. Reactive oxygen radicals in signaling and damage in the ischemic brain. J Cereb Blood Flow Metab 2001;21:2-14.
51. Fullerton HJ, Ditelberg JS, Chen SF, Sarco DP, Chan PH, Epstein CJ et al. Copper/zinc superoxide dismutase transgenic brain accumulates hydrogen peroxide after perinatal hypoxia ischemia. Ann Neurol 1998;44:357-64.
52. Van Bel F, Shadid M, Moison RM, Dorrepaal CA, Fontijn J, Monteiro L et al. Effect of allopurinol on postasphyxial free radical formation, cerebral hemodynamics, and electrical brain activity. Pediatrics 1998;10:185-93.
53. Clancy RR, McGaurn SA, Coin JE, Hirtz DG, Norwood WI, Gaynor JW et al. Allopurinol neurocardiac protection trial in infants undergoing heart surgery using deep hypothermic circulatory arrest. Pediatrics 2001; 108:61-70.
54. Nakai A, Shibazaki Y, Taniuchi Y, Oya A, Asakura H, Koshino T. Vitamins ameliorate secondary mitochondrial failure in neonatal rat brain. Ped Neurol 2002;27:30-5.
55. Wiswell TE, Robertson CF, Jones TA, Tuttle DJ. Necrotizing enterocolitis in full-term infants. A case control study. Am J Dis Child 1988;142:532-5.
56. th ed. Disease of the fetus and infant. St Louis; Mosby: 1997.p.1333-4.
57. Kolsloske AM. Pathogenesis and prevention of necrotizing enterocolitis: a hypotesis based on personal observation and review of the literature. Paediatrics 1984;74:1086-92.
58. Kolsloske AM. A unified hypotesis for pathogenesis and prevention of necrotizing enterocolitis. J Pediatr 1990;117:568-74.
59. Caplan MS, MacKendrick W. Inflammatory mediators and intestinal injury. Clin Perinatol 1994;21:235-46.
60. Potoka DA, Nadler EP, Upperman JS, Ford HR. Role of nitric oxide and peroxynitrite in gut barrier failure. Worl J Surg 2002;26:806-11.
61. Hsueh W, Caplan MS, Qu XW, Tan XD, De Plaen IG, Gonzalez-Cru. Neonatal necrotizing enterocolitis: clinical considerations and pathogenetic concepts. Pediatr Dev Pathol 2003;6:6-23.
62. Jassem W, Roake J. The molecular and cellular basis of reperfusion injury following organ transplantation. Transplant Rev 1998;12:14-33.
63. Miller NJ, Rice-Evans C, Davies MJ, Gopinathan V, Milner A. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci 1993;84:407-12.
64. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN. Bilirubin is an antioxidant of possible phisiological importance. Science 1987;235:1043-46.
65. Stocker R, Ames BN. Potential role of conjugated bilirubin and copper in the metabolism of lipid peroxides. Proc Natl Acad Sci 1987;84:5918-22.
66. Wu TW, Wu J, Li RK, Mickle D, Carey D. Albumin-bounds bilirubin protects human ventricular myocites oxy radical damage. Biochem Cell Biol 1991;69:683-8.
67. Mireles LC, Lum MA, Dennery PA. Antioxidant and cytotoxic effects of bilirubin on neonatal erythrocytes. Pediatr Res 1999;45:355-62.
68. Dennery PA, McDonagh AF, Spitz DR, Rogers PA, Stevenson DK. Hyperbilirubinemia results reduced oxidative injury in neonatal Gunn rat exposed in hyperoxia. Free Radic Biol Med 1995;19:395-404.
69. Yigit S, Yurdakok M, Kilinc K, Oran O, Erdem G, Tekinalp G. Serum malondialdehyde concentrations in babies with hyperbilirubinemia. Arch Dis Child Fetal Neonatal Ed 1999;80:F235-7.
70. Hammerman C, Goldstein R, Kaplan M, Eran M, Goldschmidt D, Eidelman AI et al. Bilirubin in the premature: toxic waste or natural defense? Clin Chem 1998;44:2551-3.
71. Kimberly K, Bonkovsky E, Bonkovsky HL. Heme oxygenase: recent advances in understanding its regulation and role. Proc Ass Am Phys 1999;111:438-47.
72. Keyse SM, Applegate LA, Tromvoukis Y, Tyrrell RM. Oxidative stress leads to transcriptional activation of the human heme oxygenase gene in cultured skin fibroblast. Mol Cell Biol 1990;10:4967-9.
73. Lautier D, Luscher P, Tyrrell RM. Endogenous glutathione levels, modulate both costitutive and UVA radiation/hyrogen peroxide inducible expression of the human heme oxygenase gene. Carcinogenesis 1992;13:227-32.
74. Dennery PA, Wong HE, Sriclav KJ, Rodgers PA, Sim JE, Spitz DR. Differeces in basal and hyperoxia-associated HO expression in oxidant-resistant hamster fibroblasts. Am J Physiol 1996;271:L672-9.
75. Applegate LA, Luscher P, Tyrrell RM. Induction of heme oxygenase: a general response to oxidant stress in cultured mammalian cells. Cancer Res 1991;51:974-8.
76. Dennery PA, Spitz DR, Yang G, Tatarov A, Lee CS, Shegog ML et al. Oxygen toxicity and iron accumulation in the lungs of mice lacking heme-oxygenase-2. J Clin Invest 1998;101:1001-11.
77. Dani C, Masini E, Bertini G, Di Felice AM, Pezzati M, Ciofini S et al. Role of heme oxygenase and bilirubin in oxidative stress in preterm infants. Pediatr Res. In press 2004.
78. Pauly TH, Smith M, Gillespie M. Bilirubin as an antioxidant: effect non group B streptococci-induced pulmonary hypertension in infant piglets. Biol Neonate 1991;60:320-6.
79. Gopinathan V, Miller NJ, Milner AD, Rice Evans CA. Bilirubin and ascorbate antioxidant activity in neonatal plasma. FEBS Lett 1994;349:197-200.
80. Bellanger S, Lavole JC, Chessex P. Influence of bilirubin on the antioxidant capacity of plasma in newborn infants. Biol Neonate 1997;71:233-8.
81. Tamion F, Richard V, Binmarchand G, Leroy J, Lebreton JP, Thuillez C. Induction of heme oxygenase-1 prevents the systemic response to hemorrhagic shock. Am J Respir Crit Care Med 2001;164:1933-8.
82. Dorè S. Decreased activity of the antioxidant heme oxygenase enzyme: implications in ischemia and Alzheimer's disease. Free Radic Biol Med 2002;32:1276-82.
83. Motterlini R, Foresti F, Vandegriff K, Intaglietta M, Winslow RM. Oxidative stress response in vascular endothelial cell exposed to acellular hemoglobin solutions. Am J Physiol 1995;269:H648-55.
84. Dennery PA. Regulation and role of heme oxygenase in oxidative injury. Curr Top Cell Regul 2000;36:181-99.
85. Ferris CD, Jeffrey SR, Sawa A, Takahashi M, Bradi SD, Barrow RK et al. Heme oxygenase-1 prevent cell death by regulating cellular iron. Nat Cell Biol 1999;3:152-7.
86. Samb A, Taillè C, Almolki A, Megret J, Staddon JM, Aubier M et al. Heme oxygenase modulates oxidant-signaled airway smooth muscle contractility: role of bilirubin. Am J Physiol 2002;283:L596-603.
87. Ndisang JF, Masini E, Mannaioni PF, Wang R. In: Wong R editor. Carbon monoxide and cardiovascular inflammation. Boca Raton, FL: CRC Press; 2002.p.165-80.
88. Mirabella C, Baronti R, Berni LA, Gai P, Ndisang JF, Masini E et al. Hemin and carbon monoxide modulate the immunological response of human basophils. Int Arch Allergy Immunol 1999;118:259-60.
89. Di Bello MG, Berni L, Gai P, Mirabella C, Ndisang JF, Masini E et al. A regulatory role of carbon monoxide in mast cells function. Inflamm Res 1998;1:S7-8.
90. Otterberin LE, Bach FH, Alam J, Soares M, Tao Lu H, Wysk M et al. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med 2000;6:422-8.